Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy.

drug-resistant epilepsy epilepsy surgery health care delivery neuromodulation public health treatment

Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
10 2022
Historique:
revised: 25 06 2022
received: 01 03 2022
accepted: 27 06 2022
pubmed: 18 7 2022
medline: 14 10 2022
entrez: 17 7 2022
Statut: ppublish

Résumé

Epilepsy surgery is the treatment of choice for patients with drug-resistant seizures. A timely evaluation for surgical candidacy can be life-saving for patients who are identified as appropriate surgical candidates, and may also enhance the care of nonsurgical candidates through improvement in diagnosis, optimization of therapy, and treatment of comorbidities. Yet, referral for surgical evaluations is often delayed while palliative options are pursued, with significant adverse consequences due to increased morbidity and mortality associated with intractable epilepsy. The Surgical Therapies Commission of the International League Against Epilepsy (ILAE) sought to address these clinical gaps and clarify when to initiate a surgical evaluation. We conducted a Delphi consensus process with 61 epileptologists, epilepsy neurosurgeons, neurologists, neuropsychiatrists, and neuropsychologists with a median of 22 years in practice, from 28 countries in all six ILAE world regions. After three rounds of Delphi surveys, evaluating 51 unique scenarios, we reached the following Expert Consensus Recommendations: (1) Referral for a surgical evaluation should be offered to every patient with drug-resistant epilepsy (up to 70 years of age), as soon as drug resistance is ascertained, regardless of epilepsy duration, sex, socioeconomic status, seizure type, epilepsy type (including epileptic encephalopathies), localization, and comorbidities (including severe psychiatric comorbidity like psychogenic nonepileptic seizures [PNES] or substance abuse) if patients are cooperative with management; (2) A surgical referral should be considered for older patients with drug-resistant epilepsy who have no surgical contraindication, and for patients (adults and children) who are seizure-free on 1-2 antiseizure medications (ASMs) but have a brain lesion in noneloquent cortex; and (3) referral for surgery should not be offered to patients with active substance abuse who are noncooperative with management. We present the Delphi consensus results leading up to these Expert Consensus Recommendations and discuss the data supporting our conclusions. High level evidence will be required to permit creation of clinical practice guidelines.

Identifiants

pubmed: 35842919
doi: 10.1111/epi.17350
pmc: PMC9562030
mid: NIHMS1820930
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2491-2506

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS122389
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States
Organisme : NHLBI NIH HHS
ID : OT2 HL161847
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL061847
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107201
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097719
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA202911
Pays : United States

Informations de copyright

© 2022 International League Against Epilepsy.

Références

Epilepsia Open. 2021 Dec;6(4):720-726
pubmed: 34608757
Lancet Neurol. 2020 Sep;19(9):748-757
pubmed: 32822635
Epilepsia. 2009 Sep;50(9):2040-52
pubmed: 19400873
JAMA Neurol. 2019 Nov 1;76(11):1352-1358
pubmed: 31380987
Arch Public Health. 2020 May 01;78:23
pubmed: 33072315
Ann Neurol. 2013 May;73(5):646-54
pubmed: 23494550
N Engl J Med. 2000 Feb 3;342(5):314-9
pubmed: 10660394
Epilepsia. 2019 Sep;60(9):1949-1959
pubmed: 31392717
Eur J Neurol. 2010 Apr;17(4):619-25
pubmed: 20039934
Neurosurgery. 2019 Jun 1;84(6):E368-E377
pubmed: 30137548
Lancet Neurol. 2021 Dec;20(12):1038-1047
pubmed: 34710360
J Neurosurg. 2012 May;116(5):1042-8
pubmed: 22304450
Epilepsy Curr. 2018 Jan-Feb;18(1):12-16
pubmed: 29844752
Epilepsia. 2012 Jan;53(1):35-43
pubmed: 21973118
Brain Stimul. 2021 Jul-Aug;14(4):1022-1031
pubmed: 34198105
Seizure. 2020 Apr;77:86-92
pubmed: 31375336
Neurology. 2015 Jan 13;84(2):159-66
pubmed: 25503624
Neurology. 2013 Oct 1;81(14):1244-51
pubmed: 23966252
Epilepsia. 2012 Sep;53(9):1587-96
pubmed: 22905763
Epilepsia. 2015 Oct;56(10):1526-33
pubmed: 26250432
Neurosurgery. 2018 Jul 1;83(1):93-103
pubmed: 29106684
Epilepsia. 2007;48 Suppl 9:13-6
pubmed: 18047593
Brain. 2009 Oct;132(Pt 10):2822-30
pubmed: 19635728
Epilepsy Curr. 2013 Sep;13(5):232-5
pubmed: 24348117
Am J Public Health. 2015 Dec;105(12):e53-9
pubmed: 26469651
Epilepsia. 2015 Mar;56(3):375-81
pubmed: 25630252
Brain. 2007 Feb;130(Pt 2):334-45
pubmed: 17124190
Lancet Neurol. 2008 Jun;7(6):514-24
pubmed: 18485315
JAMA Neurol. 2018 Mar 1;75(3):279-286
pubmed: 29279892
J Neurosurg. 2017 Nov;127(5):1147-1152
pubmed: 28084910
Epilepsia. 2020 May;61(5):841-855
pubmed: 32227349
Epilepsy Behav. 2021 Feb;115:107662
pubmed: 33339740
Eur J Paediatr Neurol. 2020 Jan;24:40-42
pubmed: 31917082
Epileptic Disord. 2020 Aug 1;22(4):421-437
pubmed: 32763869
Epilepsia. 2013 May;54(5):840-7
pubmed: 23551133
Epilepsy Behav. 2020 Jul;108:107093
pubmed: 32402704
Epilepsia. 2008 Jan;49(1):146-55
pubmed: 18042232
Epilepsia. 2010 Jul;51(7):1189-97
pubmed: 20557350
Epilepsia. 2019 May;60(5):872-884
pubmed: 30968956
Brain. 2020 Dec 5;143(11):3262-3272
pubmed: 33179036
Epilepsia. 2020 Jun;61(6):1183-1189
pubmed: 32412094
Epilepsia. 2011 Mar;52(3):619-26
pubmed: 21269287
Clin Neurol Neurosurg. 2021 Apr 20;205:106644
pubmed: 33962146
Epilepsia. 2021 Jun;62(6):1306-1317
pubmed: 33830503
Neurology. 2019 Jul 9;93(2):e159-e166
pubmed: 31182508
Epilepsia. 2001 Jan;42(1):113-8
pubmed: 11207794
Epilepsia. 2003 Jun;44(6):741-51
pubmed: 12790886
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Eur J Paediatr Neurol. 2019 May;23(3):456-465
pubmed: 31023627
Epilepsia. 2019 Sep;60(9):1768-1793
pubmed: 31407324
Neurology. 2020 Aug 11;95(6):e643-e652
pubmed: 32690794
Acta Neuropathol. 2014 Jul;128(1):55-65
pubmed: 24831066
Neurol Clin Pract. 2016 Aug;6(4):304-314
pubmed: 27574569
Neurology. 2020 Sep 8;95(10):e1404-e1416
pubmed: 32641528
Epilepsia. 2011 May;52(5):857-69
pubmed: 21426331
Epilepsia. 2015 May;56(5):717-25
pubmed: 25847357
Lancet Neurol. 2016 Aug;15(9):982-994
pubmed: 27478955
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
N Engl J Med. 2017 Oct 26;377(17):1639-1647
pubmed: 29069568
Neurology. 2018 Jul 10;91(2):e96-e106
pubmed: 29898967
Lancet. 2011 Oct 15;378(9800):1388-95
pubmed: 22000136
Epilepsy Behav. 2019 Mar;92:245-252
pubmed: 30726768
Ann Neurol. 2009 May;65(5):510-9
pubmed: 19475671
JAMA. 2012 Mar 7;307(9):922-30
pubmed: 22396514
N Engl J Med. 2017 Oct 26;377(17):1648-1656
pubmed: 29069555
Neurosurgery. 2021 Jul 15;89(2):164-176
pubmed: 33862622
J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):49-53
pubmed: 22952328
Epilepsia. 2017 Feb;58(2):181-221
pubmed: 28111749
Neurology. 2003 Jan 28;60(2):186-90
pubmed: 12552028
Ann Neurol. 1999 Jul;46(1):45-50
pubmed: 10401779
Epilepsia. 2019 Sep;60(9):1794-1796
pubmed: 31402443
Epilepsy Behav. 2021 Sep;122:108192
pubmed: 34265620
Epilepsy Behav. 2003 Dec;4(6):723-8
pubmed: 14698707
Epilepsia. 2020 Jul;61(7):1352-1364
pubmed: 32558937
Eur J Neurol. 2006 Mar;13(3):277-82
pubmed: 16618346
Epilepsia. 2019 Jun;60(6):1171-1183
pubmed: 31112302
Neurology. 2016 May 24;86(21):1938-44
pubmed: 27164679
Neurology. 2020 Sep 1;95(9):e1244-e1256
pubmed: 32690786

Auteurs

Lara Jehi (L)

Epilepsy Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Nathalie Jette (N)

Department of Neurology and Department of Population Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Churl-Su Kwon (CS)

Departments of Neurology, Epidemiology, Neurosurgery and the Gertrude H. Sergievsky Center, Columbia University, New York, New York, USA.

Colin B Josephson (CB)

Departments of Clinical Neurosciences and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Jorge G Burneo (JG)

Department of Clinical Neurological Sciences and NeuroEpidemiology Unit, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Fernando Cendes (F)

Department of Neurology, University of Campinas, Campinas, Brazil.

Michael R Sperling (MR)

Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Sallie Baxendale (S)

Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, UK.

Robyn M Busch (RM)

Epilepsy Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Chahnez Charfi Triki (CC)

Department of Child Neurology, Hedi Chaker Hospital, LR19ES15 Sfax University, Sfax, Tunisia.

J Helen Cross (JH)

UCL Great Ormond Street Institute of Child Health, London, UK.

Dana Ekstein (D)

Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah Medical Organization, Jerusalem, Israel.

Dario J Englot (DJ)

Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Guoming Luan (G)

Department of Neurosurgery, Comprehensive Epilepsy Center, Beijing Institute for Brain Disorders, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Beijing Key Laboratory of Epilepsy, Beijing, China.
Epilepsy Institution, Beijing, China.

Andre Palmini (A)

Neurosciences and Surgical Departments, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.

Loreto Rios (L)

Clínica Integral de Epilepsia, Campus Clínico Facultad de Medicina Universidad Finis Terrae, Santiago, Chile.

Xiongfei Wang (X)

Department of Neurosurgery, Comprehensive Epilepsy Center, Beijing Institute for Brain Disorders, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Beijing Key Laboratory of Epilepsy, Beijing, China.
Epilepsy Institution, Beijing, China.

Karl Roessler (K)

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Bertil Rydenhag (B)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Georgia Ramantani (G)

Department of Neuropediatrics, and University Children's Hospital Zurich, Switzerland, University of Zurich, Switzerland.

Stephan Schuele (S)

Department of Neurology, Northwestern University, Chicago, Illinois, USA.

Jo M Wilmshurst (JM)

Department of Pediatric Neurology, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Institute of Neurosciences, University of Cape Town, Cape Town, South Africa.

Sarah Wilson (S)

Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia.

Samuel Wiebe (S)

Departments of Clinical Neurosciences and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH